Emergent BioSolutions | 当期純利益



Net Income 変化する 日付
Acadia Pharmaceuticals USD 18.99M 124.76M 2025-03
ALKERMES USD 22.46M 344.61M 2025-03
Alnylam Pharmaceuticals USD -57479000 26.28M 2025-03
Amarin USD -15697000 32.92M 2025-03
ANI Pharmaceuticals USD 15.68M 25.96M 2025-03
BioMarin Pharmaceutical USD 185.69M 60.74M 2025-03
Exact Sciences USD -101215000 763.37M 2025-03
Exelixis USD 159.62M 19.76M 2025-04
Glaxosmithkline GBP 414M 472M 2024-12
Ionis Pharmaceuticals USD -146938000 42.59M 2025-03
Ironwood Pharmaceuticals USD 3.19M 457K 2024-12
Lonza CHF 307M 22M 2024-12
Merck USD 5.08B 1.34B 2025-03
Moderna USD -971000000 149M 2025-03
Myriad Genetics USD -100000 42.4M 2025-03
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
Pacira USD 4.81M 11.23M 2025-03
Pfizer USD 2.97B 2.56B 2025-03
PTC Therapeutics USD -65886000 40.77M 2024-12
Sanofi EUR 1.87B 1.37B 2025-03
Sarepta Therapeutics USD -447508000 606.56M 2025-03
United Therapeutics USD 322.2M 20.9M 2025-03



Emergent BioSolutions 当期純利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Jul 2025.